| 1 | DUPILUMAB (Dupixent) | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5]  51 51, 97, 98, 160, 162 💬
 | 
| 2 | Dupilumab (blinded) (Dupixent) | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  98 98 💬
 | 
| 3 | Dupilumab (open-label) (Dupixent) | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  98 98 💬
 | 
| 4 | Dupilumab 300Mg Solution for Injection (Dupixent) | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  51 51 💬
 | 
| 5 | Dupilumab Injection (Dupixent) | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  160 160 💬
 | 
| 6 | Dupilumab Prefilled Syringe (Dupixent) | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1]  160 160 💬
 | 
| 7 | Dupixent | [1]  Dupilumab Dupilumab (Dupixent) | [1]  Dupilumab 
                
                    Dupilumab
                
             (Dupixent) 💬
 | [1]  IL4R IL4R 💬
 | [8]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [3]  98 98, 160, 162 💬
 |